In October 2024, Omron Healthcare received de novo authorisation from the US Food and Drugs Administration (FDA) to market ...

But new research finds that on extremely hot days, people with the devices face nearly triple the odds for a dangerous arrhythmia known as atrial fibrillation, compared to days with cooler ...

The company uses a novel machine-learning algorithm, called IntelliSense AFib, to analyze pressure pulse waves generated ...

OMRON Healthcare has secured De Novo authorisation from the US Food and Drug Administration (FDA) for new home blood pressure ...